It has been widely reported that higher S100A16 mRNA expression in lung adenocarcinoma was significantly associated with poorer survival, and the subcellular localization of S100A16 and S100A16 mRNA expression levels are prognostic markers in LUAD (Kobayashi et al.2018). This evidence concerns the gene S100A16 and lung adenocarcinoma.